Machine Learning, data

Routinize Machine Learning to Realize Biotech Gains

The biotech industry needs a data interchange standard that translates like the batch machine learning and XML standards that are used in manufacturing but are not yet used between R&D and manufacturing. When such a standard is developed, implementing machine learning will be simpler than ever.
Release of monoclonal antibodies, illustration

Better Antibodies for Bioprocessing

Using the appropriate technology for improving the results of research and development can improve the final product.

Novavax Ramps Up Manufacturing of COVID-19 Candidate with $167M Acquisition of Praha Vaccines

Praha Vaccines’ assets include a 150,000-square foot vaccine and biologics manufacturing facility and other support buildings in Bohumil, Czech Republic, which Novavax expects will deliver an annual capacity of over 1 billion doses of antigen starting in 2021 for NVX-CoV2373, the company's COVID-19 vaccine candidate.

Pfenex Scores Government Contract to Develop Production Process for Bulk Recombinant Protective Antigen from...

BARDA funding could total $18.8 million if all milestones are met and options and extensions are made.

Quanterix Set to Launch IPO, with Expansion and SR-X Rollout in Mind

Quanterix plans to launch an IPO of at least $64 million, with proceeds set in part toward expanding commercial operations and supporting the planned rollout next year of its new Quanterix SR-X Ultra-Sensitive Biomarker Detection System™
filtration workflow

Filtration Focuses on Capacity and Concentration Pain Points

A therapeutic protein or monoclonal antibody (mAb) can be turned into an effective therapy and a revenue-generating product only if it can be efficiently filtered from the process stream. If a product is inefficiently...
BioSettler

Single-Use Technology: Enjoy the Upsides, Handle the Downsides

When new technologies are deployed, there’s always a fly in the ointment. In the case of single-use technology, extractables and leachables must be swatted away.
RoosterBio scientists

Fledgling Steps toward Regenerative Medicine Superpowers

Regenerative medicine looks forward to the industrial-scale production of diverse tissues. Eventually, treatments may grant patients something like the powers of a superhero—a Salamander Man—when needed.
scientists in clean room

How Effective Buffer Management Facilitates Biopharmaceutical Production

Biopharmaceutical production depends on buffers. Making sure the right buffer solutions are available, in the right place on the manufacturing line, at the right time, and in the right quantity, is a considerable challenge.
Macular Degeneration

Large-Scale Automation Promises to Help Treat Macular Degeneration

French scientists developed a protocol where hPSC cells were exposed to three different cytokines in sequence. This protocol was then transferred to a cell culture robot to help upscale the production process. The approach allowed the team to increase the yield of RPE cells they could obtain and allowed them to use automatic treatments.

Recently Featured

Scroll Up